Sabra Healthcare REIT received a Hold rating and a $20.00 price target from Wedbush analyst Richard Anderson on September 30. The company’s shares closed yesterday at $18.36.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
According to TipRanks, Anderson is a 4-star analyst with an average return of 8.4% and a 68.31% success rate. Anderson covers the Real Estate sector, focusing on stocks such as AvalonBay, Douglas Emmett, and Safehold.
Sabra Healthcare REIT has an analyst consensus of Moderate Buy, with a price target consensus of $20.55.
SBRA market cap is currently $4.4B and has a P/E ratio of 24.52.
Read More on SBRA:
Disclaimer & DisclosureReport an Issue
- Sabra Health Care initiated with a Neutral at Cantor Fitzgerald
- Sabra Health Care price target raised to $20 from $18 at Truist
- Sunshine Retirement Living signs agreement with Sabra Health Care
- Sabra Healthcare Reit: Positive Earnings Call Highlights
- Sabra Health Care price target raised to $22 from $20 at Citizens JMP